|
1
|
Stewart BW and Wild CP: World Cancer
Report, 2014. IARC, WHO Press; Lyon, France: 2014
|
|
2
|
Chen WQ, Zheng RS, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:1152016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li L, Feng T, Qu J, Feng N, Wang Y, Ma RN,
Li X, Zheng ZJ, Yu H and Qian B: LncRNA expression signature in
prediction of the prognosis of lung adenocarcinoma. Genet Test Mol
Biomarkers. 22:20–28. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bhattacharjee A, Richards WG, Staunton J,
Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, et
al: Classification of human lung carcinomas by mRNA expression
profiling reveals distinct adenocarcinoma subclasses. Proc Natl
Acad Sci USA. 98:13790–13795. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lin JJ, Cardarella S, Lydon CA, Dahlberg
SE, Jackman DM, Jänne PA and Johnson BE: Five-year survival in
EGFR-mutant metastatic lung adenocarcinoma treated with EGFR-TKIs.
J Thorac Oncol. 11:556–565. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Devarakonda S, Morgensztern D and Govindan
R: Genomic alterations in lung adenocarcinoma. Lancet Oncol.
16:e342–e351. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Galvan A, Frullanti E, Anderlini M,
Manenti G, Noci S, Dugo M, Ambrogi F, De Cecco L, Spinelli R,
Piazza R, et al: Gene expression signature of non-involved lung
tissue associated with survival in lung adenocarcinoma patients.
Carcinogenesis. 34:2767–2773. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qiu M, Xu Y, Yang X, Wang J, Hu J, Xu L
and Yin R: CCAT2 is a lung adenocarcinoma-specific long non-coding
RNA and promotes invasion of non-small cell lung cancer. Tumour
Biol. 35:5375–5380. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu Y, Liu HB, Shi XF, Yao YW, Yang W and
Song Y: The long non-coding RNA HNF1A-AS1 regulates proliferation
and metastasis in lung adenocarcinoma. Oncotarget. 6:9160–9172.
2015.PubMed/NCBI
|
|
11
|
Li DS, Ainiwaer JL, Sheyhiding I, Zhang Z
and Zhang LW: Identification of key long non-coding RNAs as
competing endogenous RNAs for miRNA-mRNA in lung adenocarcinoma.
Eur Rev Med Pharmacol Sci. 20:2285–2295. 2016.PubMed/NCBI
|
|
12
|
Rousseaux S, Debernardi A, Jacquiau B,
Vitte AL, Vesin A, Nagy-Mignotte H, Moro-Sibilot D, Brichon PY,
Lantuejoul S, Hainaut P, et al: Ectopic activation of germline and
placental genes identifies aggressive metastasis-prone lung
cancers. Sci Transl Med. 5:186ra1662013. View Article : Google Scholar
|
|
13
|
Botling J, Edlund K, Lohr M, Hellwig B,
Holmberg L, Lambe M, Berglund A, Ekman S, Bergqvist M, Pontén F, et
al: Biomarker discovery in non-small cell lung cancer: Integrating
gene expression profiling, meta-analysis, and tissue microarray
validation. Clin Cancer Res. 19:194–204. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Der SD, Sykes J, Pintilie M, Zhu CQ,
Strumpf D, Liu N, Jurisica I, Shepherd FA and Tsao MS: Validation
of a histology-independent prognostic gene signature for
early-stage, non-small-cell lung cancer including stage IA
patients. J Thorac Oncol. 9:59–64. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Selamat SA, Chung BS, Girard L, Zhang W,
Zhang Y, Campan M, Siegmund KD, Koss MN, Hagen JA, Lam WL, et al:
Genome-scale analysis of DNA methylation in lung adenocarcinoma and
integration with mRNA expression. Genome Res. 22:1197–1211. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Girard L, Rodriguez-Canales J, Behrens C,
Thompson DM, Botros IW, Tang H, Xie Y, Rekhtman N, Travis WD,
Wistuba II, et al: An expression signature as an aid to the
histologic classification of non-small cell lung cancer. Clin
Cancer Res. 22:4880–4889. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Landi MT, Dracheva T, Rotunno M, Figueroa
JD, Liu H, Dasgupta A, Mann FE, Fukuoka J, Hames M, Bergen AW, et
al: Gene expression signature of cigarette smoking and its role in
lung adenocarcinoma development and survival. PLoS One.
3:e16512008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kabbout M, Garcia MM, Fujimoto J, Liu DD,
Woods D, Chow CW, Mendoza G, Momin AA, James BP, Solis L, et al:
ETS2 mediated tumor suppressive function and MET oncogene
inhibition in human non-small cell lung cancer. Clin Cancer Res.
19:3383–3395. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Parrish RS and Spencer HJ III: Effect of
normalization on significance testing for oligonucleotide
microarrays. J Biopharm Stat. 14:575–589. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bolstad BM, Irizarry RA, Astrand M and
Speed TP: A comparison of normalization methods for high density
oligonucleotide array data based on variance and bias.
Bioinformatics. 19:185–193. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Larkin MA, Blackshields G, Brown NP,
Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm
A, Lopez R, et al: Clustal W and Clustal X version 2.0.
Bioinformatics. 23:2947–2948. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhai X, Xue Q, Liu Q, Guo Y and Chen Z:
Colon cancer recurrence-associated genes revealed by WGCNA
co-expression network analysis. Mol Med Rep. 16:6499–6505. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Langfelder P and Horvath S: WGCNA: An R
package for weighted correlation network analysis. BMC
Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chong QI, Hong L, Cheng Z and Yin Q:
Identification of metastasis-associated genes in colorectal cancer
using metaDE and survival analysis. Oncol Lett. 11:568–574. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang XB, Kang DD, Shen K, Song C, Lu S,
Chang LC, Liao SG, Huo Z, Tang S, Ding Y, et al: An R package suite
for microarray meta-analysis in quality control, differentially
expressed gene analysis and pathway enrichment detection.
Bioinformatics. 28:2534–2536. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tibshirani R: The lasso method for
variable selection in the Cox model. Stat Med. 16:385–395. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Goeman JJ: L1 penalized estimation in the
Cox proportional hazards model. Biom J. 52:70–84. 2010.PubMed/NCBI
|
|
29
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kruer TL, Dougherty SM, Reynolds L, Long
E, de Silva T, Lockwood WW and Clem BF: Expression of the lncRNA
maternally expressed gene 3 (MEG3) contributes to the control of
lung cancer cell proliferation by the Rb pathway. PLoS One.
11:e01663632016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu J, Wan L, Lu KH, Sun M, Pan X, Zhang
P, Lu B, Liu G and Wang Z: The long noncoding RNA MEG3 contributes
to cisplatin resistance of human lung adenocarcinoma. PLoS One.
10:e01145862015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Watanabe N, Madaule P, Reid T, Ishizaki T,
Watanabe G, Kakizuka A, Saito Y, Nakao K, Jockusch BM and Narumiya
S: p140mDia, a mammalian homolog of Drosophila diaphanous, is a
target protein for Rho small GTPase and is a ligand for profilin.
EMBO J. 16:3044–3056. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gasman S, Kalaidzidis Y and Zerial M: RhoD
regulates endosome dynamics through Diaphanous-related Formin and
Src tyrosine kinase. Nat Cell Biol. 5:195–204. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun J, Li H, Huo Q, Cui M, Ge C, Zhao F,
Tian H, Chen T, Yao M and Li J: The transcription factor FOXN3
inhibits cell proliferation by downregulating E2F5 expression in
hepatocellular carcinoma cells. Oncotarget. 7:43534–43545.
2016.PubMed/NCBI
|
|
35
|
Li S, Xu Y, Sun Z, Feng L, Shang D, Zhang
C, Shi X, Han J, Su F, Yang H, et al: Identification of a lncRNA
involved functional module for esophageal cancer subtypes. Mol
Biosyst. 12:3312–3323. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Watanabe G, Saito Y, Madaule P, Ishizaki
T, Fujisawa K, Morii N, Mukai H, Ono Y, Kakizuka A and Narumiya S:
Protein kinase N (PKN) and PKN-related protein rhophilin as targets
of small GTPase Rho. Science. 271:645–648. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lal MA, Andersson AC, Katayama K, Xiao Z,
Nukui M, Hultenby K, Wernerson A and Tryggvason K: Rhophilin-1 is a
key regulator of the podocyte cytoskeleton and is essential for
glomerular filtration. J Am Soc Nephrol. 26:647–662. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lu L, Yu X, Zhang L, Ding X, Pan H, Wen X,
Xu S, Xing Y, Fan J, Ge S, et al: The long non-coding RNA
RHPN1-AS1promotes uveal melanoma progression. Int J Mol Sci.
18:E2262017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kornienko AE, Guenzl PM, Barlow DP and
Pauler FM: Gene regulation by the act of long non-coding RNA
transcription. BMC Biol. 11:592013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hirohashi S and Kanai Y: Cell adhesion
system and human cancer morphogenesis. Cancer Sci. 52:575–581.
2004.
|
|
42
|
Liu Y, Wu BQ, Geng H, Xu ML and Zhong HH:
Association of chemokine and chemokine receptor expression with the
invasion and metastasis of lung carcinoma. Oncol Lett.
10:1315–1322. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang Y, Du W, Chen Z and Xiang C:
Upregulation of PD-L1 by SPP1 mediates macrophage polarization and
facilitates immune escape in lung adenocarcinoma. Exp Cell Res.
359:449–457. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yeo MK, Choi SY, Seong IO, Suh KS, Kim JM
and Kim KH: Association of PD-L1 expression and PD-L1 gene
polymorphism with poor prognosis in lung adenocarcinoma and
squamous cell carcinoma. Hum Pathol. 68:103–111. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Miller A, Mcleod L, Alhayyani S, Szczepny
A, Watkins DN, Chen W, Enriori P, Ferlin W, Ruwanpura S and Jenkins
BJ: Blockade of the IL-6 trans-signalling STAT3 axis suppresses
cachexia in Kras-induced lung adenocarcinoma. Oncogene.
36:3059–3066. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wei C, Wang W, Pang W, Meng M, Jiang L,
Xue S, Xie Y, Li R and Hou Z: The CIK cells stimulated with
combination of IL-2 and IL-15 provide an improved cytotoxic
capacity against human lung adenocarcinoma. Tumour Biol.
35:1997–2007. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Dong L, Jensen RV, De Rienzo A, Gordon GJ,
Xu Y, Sugarbaker DJ and Bueno R: Differentially expressed
alternatively spliced genes in malignant pleural mesothelioma
identified using massively parallel transcriptome sequencing. BMC
Med Genet. 10:1492009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tan X and Chen M: MYLK and MYL9 expression
in non-small cell lung cancer identified by bioinformatics analysis
of public expression data. Tumour Biol. 35:12189–12200. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Puxeddu I, Bader R, Piliponsky AM, Reich
R, Levi-Schaffer F and Berkman N: The CC chemokine eotaxin/CCL11
has a selective profibrogenic effect on human lung fibroblasts. J
Allergy Clin Immunol. 117:103–110. 2006. View Article : Google Scholar : PubMed/NCBI
|
